jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

June. 11, 2024

June. 11, 2024

jRCT1051240060

Study on effectiveness and convalescence prediction factor of the cure for the progress hepatocellular carcinoma

Study on effectiveness and convalescence prediction factor of the cure for the progress hepatocellular carcinoma

Nishimura Naoki

Nara Medical University

840 Shijo-Cho, Kashihara, Nara, Japan

+81-745-22-3051

K147051@naramed-u.ac.jp

Nishimura Naoki

Nara Medical University

840 Shijo-Cho, Kashihara, Nara, Japan

+81-745-22-3051

na0k1nnn@yahoo.co.jp

Pending

June. 11, 2024

500

Observational

single arm study

open(masking not used)

uncontrolled control

single assignment

diagnostic purpose

The patient who performed radio wave cautery therapy, hepatic artery embolus therapy, hepatic artery intraarterial injection therapy, chemotherapy for a hepatocellular carcinoma on after January 1, 2015

The patient who was able to confirm a declaration of intention of the participation refusal

No limit
No limit

Both

hepatocellular carcinoma

hepatocellular carcinoma

D006528

overall survivals

Tumor shrinkage effect
Side effects
Blood tests: CBC, prothrombin time, various blood biochemistry (AST, ALT, ALP, gamma-GTP, T-Bil, Alb, Cre, BUN, CRP), tumor markers (AFP(L3), PIVKA-II)
Performancs status
Progression free survival

Nara Medical University
Nara Medical University Certified Review Board
840 Shijo-Cho, Kashihara, Nara, Japan, Nara

+81-744-29-8835

ethics_nara@naramed-u.ac.jp

No

none